[Explanation] On March 28, the Press Office of the Hainan Provincial Government held a press conference in the Boao Lecheng Pioneer District, announcing that the Pioneer District had achieved major system and mechanism breakthroughs. The press conference introduced that the "Interim Measures for the Management of the Use of Clinically Urgently Imported Drugs in the Boao Lecheng International Medical Tourism Pioneering Zone in Hainan's Boao International Medical Tourism Pioneering Zone" was recently approved, allowing patients to take only a small number of oral clinically urgently needed imported drugs out of the piloting zone use.
[Explanation] In December 2018, the State Council granted the Hainan Provincial Government the right to approve the clinically-imported drugs in the Lecheng Pioneer District. This special preferential policy allows patients to use the developed countries such as Europe and the United States, which have been marketed but have not yet approved them in China. Register the latest medicine imported. As of March 27, 2020, 63 batches of 64 varieties of clinically urgently needed drugs and medical devices have been approved for import, and have been used in 285 patients.
[Explanation] However, according to relevant laws and regulations, patients still have restrictions on the use of clinically needed imported drugs, that is, they must be used in designated medical institutions in the Lecheng Pioneer Zone, drugs cannot be taken out of the Pioneer Zone, and some patients have chronic diseases. Inconvenience for patients who require long-term medication.
[Contemporary] (Gu Gang, Director General of the Boao Lecheng International Medical Tourism Pioneer District Administration, Hainan) With the introduction of the interim measures for drug removal from the park, our patients can take the drug out of the park after the first hospitalization. Of patients in the Mainland of China provide great convenience. Especially for patients with tumors who need to take oral medicines for a long time, they no longer need to buy them abroad, and they are not limited to use in the park, which is a very convenient for the patient's experience.
[Explanation] Jia Ning, director of the Drug Administration of Hainan Province, said that the "Interim Measures" have two obvious characteristics: First, patients must sign a written informed consent and a letter of commitment from the hospital, promising to import clinically needed drugs for personal use only, and cooperate Supervision and monitoring. The second is to implement "one medicine, one strategy" for each patient.
[Contemporary] (Jia Ning, Director of the Drug Administration of Hainan Province) The interim measures clarified that medical institutions should formulate a discharge plan and emergency plan for each patient based on the actual situation of different patients who need to continue to use clinically-imported drugs. Patients can take away a small amount of oral clinically needed imported drugs for personal use only from the advance zone.
[Explanation] According to the introduction, the implementation of the "Interim Measures" will effectively solve the problem that patients must be hospitalized every time they use clinically needed imported drugs, greatly reducing the cost of medication and making it easier for patients at home and abroad to diagnose and treat.
Reporter Zhang Qianyi Lin Shijie reports from Boao, Hainan
Editor-in-chief: [Qi Bin]